Terms: = Lung cancer AND MAP3K1, ENSG00000095015, 4214, Q13233, MEKK1, MEKK, MAPKKK1 AND Treatment
11 results:
1. Dexamethasone activates c-Jun NH2-terminal kinase (JNK) which interacts with GR and protects it from ubiquitin-mediated degradation in NSCLC cells.
Srivastava S; Siddiqui S; Chowdhury S; Trivedi AK
Biochem Biophys Res Commun; 2023 Apr; 650():1-8. PubMed ID: 36764207
[TBL] [Abstract] [Full Text] [Related]
2. MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with lung cancers Driven by
Sato H; Schoenfeld AJ; Siau E; Lu YC; Tai H; Suzawa K; Kubota D; Lui AJW; Qeriqi B; Mattar M; Offin M; Sakaguchi M; Toyooka S; Drilon A; Rosen NX; Kris MG; Solit D; De Stanchina E; Davare MA; Riely GJ; Ladanyi M; Somwar R
Clin Cancer Res; 2020 Jun; 26(12):2932-2945. PubMed ID: 32122926
[TBL] [Abstract] [Full Text] [Related]
3. DIAPH3 promotes the tumorigenesis of lung adenocarcinoma.
Xiang G; Weiwei H; Erji G; Haitao M
Exp Cell Res; 2019 Dec; 385(1):111662. PubMed ID: 31586548
[TBL] [Abstract] [Full Text] [Related]
4. Prolonged overall survival following metastasectomy in stage IV melanoma.
Elias ML; Behbahani S; Maddukuri S; John AM; Schwartz RA; Lambert WC
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1719-1725. PubMed ID: 31070816
[TBL] [Abstract] [Full Text] [Related]
5. A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project.
Mochamat ; Cuhls H; Marinova M; Kaasa S; Stieber C; Conrad R; Radbruch L; Mücke M
J Cachexia Sarcopenia Muscle; 2017 Feb; 8(1):25-39. PubMed ID: 27897391
[TBL] [Abstract] [Full Text] [Related]
6. Non-thermal plasma treatment altered gene expression profiling in non-small-cell lung cancer A549 cells.
Hou J; Ma J; Yu KN; Li W; Cheng C; Bao L; Han W
BMC Genomics; 2015 Jun; 16(1):435. PubMed ID: 26116417
[TBL] [Abstract] [Full Text] [Related]
7. The Accomplices of NF-κB Lead to Radioresistance.
Bai M; Ma X; Li X; Wang X; Mei Q; Li X; Wu Z; Han W
Curr Protein Pept Sci; 2015; 16(4):279-94. PubMed ID: 25929862
[TBL] [Abstract] [Full Text] [Related]
8. Genetic variations in multiple drug action pathways and survival in advanced stage non-small cell lung cancer treated with chemotherapy.
Li Y; Sun Z; Cunningham JM; Aubry MC; Wampfler JA; Croghan GA; Johnson C; Wu D; Aakre JA; Molina J; Wang L; Pankratz VS; Yang P
Clin Cancer Res; 2011 Jun; 17(11):3830-40. PubMed ID: 21636554
[TBL] [Abstract] [Full Text] [Related]
9. Racial variation in willingness to trade financial resources for life-prolonging cancer treatment.
Martin MY; Pisu M; Oster RA; Urmie JM; Schrag D; Huskamp HA; Lee J; Kiefe CI; Fouad MN
Cancer; 2011 Aug; 117(15):3476-84. PubMed ID: 21523759
[TBL] [Abstract] [Full Text] [Related]
10. Inhibition of nuclear factor-kappaB augments antitumor activity of adenovirus-mediated melanoma differentiation-associated gene-7 against lung cancer cells via mitogen-activated protein kinase kinase kinase 1 activation.
Oida Y; Gopalan B; Miyahara R; Branch CD; Chiao P; Chada S; Ramesh R
Mol Cancer Ther; 2007 Apr; 6(4):1440-9. PubMed ID: 17431123
[TBL] [Abstract] [Full Text] [Related]
11. Defective stress kinase and Bak activation in response to ionizing radiation but not cisplatin in a non-small cell lung carcinoma cell line.
Viktorsson K; Ekedahl J; Lindebro MC; Lewensohn R; Zhivotovsky B; Linder S; Shoshan MC
Exp Cell Res; 2003 Oct; 289(2):256-64. PubMed ID: 14499626
[TBL] [Abstract] [Full Text] [Related]
